Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks
Open accessThe DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Abstract
Staphylococcus aureus has long been recognized as an important pathogen in human disease. Due to an increasing number of infections caused by methicillin-resistant S. aureus (MRSA) strains, therapy has become problematic. Therefore, prevention of staphylococcal infections has become more important. Carriage of S. aureus appears to play a key role in the epidemiology and pathogenesis of infection. The ecological niches of S. aureus are the anterior nares. In healthy subjects, over time, three patterns of carriage can be distinguished: about 20% of people are persistent carriers, 60% are intermittent carriers, and approximately 20% almost never carry S. aureus. The molecular basis of the carrier state remains to be elucidated. In patients who repeatedly puncture the skin (e.g., hemodialysis or continuous ambulatory peritoneal dialysis [CAPD] patients and intravenous drug addicts) and patients with human immunodeficiency virus (HIV) infection, increased carriage rates are found. Carriage has been identified as an important risk factor for infection in patients undergoing surgery, those on hemodialysis or CAPD, those with HIV infection and AIDS, those with intravascular devices, and those colonized with MRSA. Elimination of carriage has been found to reduce the infection rates in surgical patients and those on hemodialysis and CAPD. Elimination of carriage appears to be an attractive preventive strategy in patients at risk. Further studies are needed to optimize this strategy and to define the groups at risk.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“People who misuse drugs have a higher rate of nasal or skin colonization with S. aureus than the general population (2, 14).”
From Methicillin-Resistant Staphylococcus aureus Nasal Carriage among Injection Drug Users: Six Years Later (2008) · cites this paper as [14]
In the citing paper
“S. aureus nasal carriage, present in about 20% of the general population, has been identified as a risk factor for the subsequent development of community-acquired and nosocomial staphylococcal infections (14, 22).”
From Methicillin-Resistant Staphylococcus aureus Nasal Carriage among Injection Drug Users: Six Years Later (2008) · cites this paper as [14]
In the citing paper
“S. aureus nasal carriage, present in about 20% of the general population, has been identified as a risk factor for the subsequent development of community-acquired and nosocomial staphylococcal infections (14, 22).”
From Methicillin-Resistant Staphylococcus aureus Nasal Carriage among Injection Drug Users: Six Years Later (2008) · cites this paper as [14]
In the citing paper
“Carriage of S. aureus is a significant risk factor for nosocomial invasive infections by S. aureus (Kluytmans et al., 1997).”
From Nasal Microenvironments and Interspecific Interactions Influence Nasal Microbiota Complexity and S. aureus Carriage (2013) · cites this paper as Kluytmans et al., 1997
Citations
Cites
An overview of nosocomial infections, including the role of the microbiology laboratory
Emori, T. G., & Gaynes, R. P. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.4.428 · Cited by 1,286 · cited 1×
“In 1992, resistance had increased to nearly 8% (66).”
BackgroundThe Spectrum of Vasculitis: Clinical, Pathologic, Immunologic, and Therapeutic Considerations
FAUCI, A. S., HAYNES, B. F., & KATZ, P. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-5-660 · Cited by 1,196 · cited 1×
“Wegener’s granulomatosis is a systemic disease characterized by necrotizing granulomatous inflammation of the upper and lower respiratory tract in combination with vasculitis and focal necrotizing crescentic glomerulonephritis (52).”
BackgroundMSCRAMM-MEDIATED ADHERENCE OF MICROORGANISMS TO HOST TISSUES
Patti, J. M., Allen, B. L., McGavin, M. J., & Höök, M. (1994) · Annual Review of Microbiology · doi:10.1146/annurev.mi.48.100194.003101 · Cited by 1,191
Major trends in the microbial etiology of nosocomial infection
Schaberg, D. R., Culver, D. H., & Gaynes, R. P. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90346-y · Cited by 1,109 · cited 1×
“aureus is the second most prevalent organism causing intravascular device-associated bacteremia (111, 165).”
BackgroundMethicillin-ResistantStaphylococcus aureus in Europe
Voss, A., Milatovic, D., Wallrauch-Schwarz, C., Rosdahl, V. T., & Braveny, I. (1994) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02026127 · Cited by 801
Stegeman, C. A., Tervaert, J. W. C., Sluiter, W. J., Manson, W. L., de Jong, P. E., & Kallenberg, C. G. M. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-1-199401010-00003 · Cited by 729
Prevention and Control of Nosocomial Infections.
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-5-791_4 · Cited by 719
Methicillin-Resistant Staphylococcus aureus in U.S. Hospitals, 1975–1991
Panlilio, A. L., Culver, D. H., Gaynes, R. P., Banerjee, S., Henderson, T. S., Tolson, J. S., Martone, W. J., & System, N. N. I. S. (1992) · Infection Control & Hospital Epidemiology · doi:10.1086/646432 · Cited by 657
Mulligan, M. E., Murray-Leisure, K. A., Ribner, B. S., Standiford, H. C., John, J. F., Korvick, J. A., Kauffman, C. A., & Yu, V. L. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90063-u · Cited by 641
Noble, W. C., Virani, Z., & Cree, R. G. A. (1992) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1992.tb05089.x · Cited by 627
Cited by
Items 501–600 of 1,002
Antibiotic tolerance and the alternative lifestyles of Staphylococcus aureus
Bui, L. M. G., Conlon, B. P., & Kidd, S. P. (2017) · Essays in Biochemistry · doi:10.1042/ebc20160061 · Cited by 64
Campoccia, D., Baldassarri, L., Pirini, V., Ravaioli, S., Montanaro, L., & Arciola, C. R. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.07.006 · Cited by 63
“It can often be found as a commensal and a transient or persistent part of the resident flora of the skin and anterior nares in a large proportion (20–50%) of the human population [1,2].”
BackgroundCharacteristics of a new epidemic MRSA in Germany ancestral to United Kingdom EMRSA 15
Witte, W., Enright, M. C., Schmitz, F., Cuny, C., Braulke, C., & Heuck, D. (2001) · International Journal of Medical Microbiology · doi:10.1016/s1438-4221(01)80006-0 · Cited by 63
Rodgers, J. D., McCullagh, J. J., McNamee, P. T., Smyth, J. A., & Ball, H. J. (1999) · Veterinary Microbiology · doi:10.1016/s0378-1135(99)00112-1 · Cited by 63
Andersen, P. S., Pedersen, J. K., Fode, P., Skov, R. L., Fowler, V. G., Stegger, M., & Christensen, K. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis491 · Cited by 63
“3%, which shows good accordance with these general findings as well as with the average prevalence estimate of 27% [18].”
BackgroundAntistaphylococcal activity of bacteriophage derived chimeric protein P128
Vipra, A. A., Desai, S. N., Roy, P., Patil, R., Raj, J. R. M., Narasimhaswamy, N., Paul, V. D., Chikkamadaiah, R., & Sriram, B. (2012) · BMC Microbiology · doi:10.1186/1471-2180-12-41 · Cited by 63
“aureus in humans; 80% of the human population may be carriers [3].”
BackgroundWeems, J. J. (2001) · Postgraduate Medicine · doi:10.3810/pgm.2001.10.1042 · Cited by 62
Hofstee, M. I., Riool, M., Terjajevs, I., Thompson, K., Stoddart, M. J., Richards, R. G., Zaat, S. A. J., & Moriarty, T. F. (2020) · Infection and Immunity · doi:10.1128/iai.00293-20 · Cited by 62
Tălăpan, D., Sandu, A.-M., & Rafilă, A. (2023) · Antibiotics · doi:10.3390/antibiotics12060974 · Cited by 62
“Approximately 20% of people are long-term carriers [4].”
BackgroundRahman, M., Amin, K. B., Rahman, S. M. M., Khair, A., Rahman, M., Hossain, A., Rahman, A. K. M. A., Parvez, M., Miura, N., & Alam, M. M. (2018) · BMC Veterinary Research · doi:10.1186/s12917-018-1611-0 · Cited by 62
Stelzner, K., Boyny, A., Hertlein, T., Sroka, A., Moldovan, A., Paprotka, K., Kessie, D. K., Mehling, H., Potempa, J., Ohlsen, K., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009874 · Cited by 62
The Allergic March from Staphylococcus aureus Superantigens to Immunoglobulin E
Gould, H. J., Takhar, P., Harries, H. E., Chevretton, E. B., & Sutton, B. J. (2007) · KARGER eBooks · doi:10.1159/000100861 · Cited by 62
Antibacterial Activity of Propolis Against MRSA and Synergism with Topical Mupirocin
Önlen, Y., Duran, N., Atık, E., Savaş, L., Altuğ, M. E., Yakan, S., & Aslantaş, Ö. (2007) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2007.7021 · Cited by 62
“5,20 Topical mupirocin has been used widely for the clearance of nasal MRSA carriage during outbreaks.”
Protective immune responses to a multi-gene DNA vaccine against Staphylococcus aureus
Gaudreau, M., Lacasse, P., & Talbot, B. G. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.09.043 · Cited by 63
“[1] Kluytmans J, van Belkum A, Verbrugh H.”
BackgroundSeverin, J. A., Lestari, E. S., Kuntaman, K., Melles∗, D. C., Pastink, M., Peeters, J. K., Snijders, S. V., Hadi, U., Duerink, D. O., van Belkum, A., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01173-07 · Cited by 63
“Humans are a natural reservoir of Staphylococcus aureus, with the moist squamous epithelium of the anterior nares acting as the primary ecological niche (12, 33).”
BackgroundSelf-citationBacteriological and molecular investigations of Staphylococcus aureus in dairy goats
Mørk, T., Kvitle, B., Mathisen, T., & Jørgensen, H. J. (2009) · Veterinary Microbiology · doi:10.1016/j.vetmic.2009.08.019 · Cited by 62
Epidemiology of Methicillin-Resistant Staphylococcus aureus
Flückiger, U. M., & Widmer, A. F. (1999) · Chemotherapy · doi:10.1159/000007173 · Cited by 62
Singh, A., Singh, A., Shukla, S., Agarwal, L., & Chaturvedi, P. (2014) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.139293 · Cited by 61
Host–pathogen interactions in epidermolysis bullosa patients colonized with Staphylococcus aureus
van der Kooi‐Pol, M. M., Duipmans, J. C., Jonkman, M. F., & van Dijl, J. M. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.11.012 · Cited by 62
Tebaldi, V. M. R., de Oliveira, T. L. C., Boari, C. A., & Píccoli, R. H. (2008) · Food Science and Technology · doi:10.1590/s0101-20612008000300036 · Cited by 61
Egyir, B., Guardabassi, L., Nielsen, S. S., Larsen, J., Addo, K. K., Newman, M. J., & Larsen, A. R. (2013) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2013.05.006 · Cited by 61
“aureus carriage [18], but this study only found an association between nasal carriage of S.”
BackgroundStaphylococcus aureus virulence factors and disease
Costa, A. R., Batistão, D. W. D. F., Ribas, R. M., Sousa, A. M., Pereira, M. O., & Botelho, C. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 62
van Rijen, M. M. L., Bode, L. G. M., Baak, D. A., Kluytmans, J. A. J. W., & Vos, M. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043065 · Cited by 61
“aureus nasal carriage is now considered to be a well-defined risk factor for subsequent infection in various groups of patients, especially those on dialysis; with cirrhosis of the liver; undergoing surgery; and with intravascular devices or in intensive care [3,8].”
BackgroundSelf-citationCharacteristics of Staphylococcus aureus Strains Isolated from Human and Animal Sources
El-Jakee, J. K., Nagwa, A. S., Bakry, M. A., Zoulfakar, S. A., & Elgabry, E. A. (2008) · Cited by 61
Staphylococcal Protein A Contributes to Persistent Colonization of Mice with Staphylococcus aureus
Sun, Y., Emolo, C., Holtfreter, S., Wiles, S., Kreiswirth, B. N., Missiakas, D. M., & Schneewind, O. (2018) · Journal of Bacteriology · doi:10.1128/jb.00735-17 · Cited by 61
“aureus colonization predisposes individuals to both community- and hospital-acquired infections (6, 14, 58).”
BackgroundSchäfer, D., Lâm, T.-T., Geiger, T., Mainiero, M., Engelmann, S., Hussain, M., Bosserhoff, A., Frosch, M., Bischoff, M., Wolz, C., et al. (2009) · Journal of Bacteriology · doi:10.1128/jb.00630-09 · Cited by 51
Petrosillo, N., Viale, P., Nicastri, E., Arici, C., Bombana, E., Casella, A., Cristini, F., De Gennaro, M., Dodi, F., Gabbuti, A., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/338813 · Cited by 57
Bhuiyan, M. A. R., Islam, A., Islam, S., Hossain, A., & Nahar, K. (2017) · Textiles and Clothing Sustainability · doi:10.1186/s40689-016-0023-4 · Cited by 60
“The pathogenic gram-positive bacterium S. aureus is the most frequently evaluated species, commonly found in the nose, respiratory tract, and on the skin, the major cause of cross-infection in hospitals as well as in commercial and home laundry practices (Kluytmans et al. 1997).”
BackgroundThe temporal dynamics of bacterial communities across human anterior nares
Camarinha‐Silva, A., Jáuregui, R., Pieper, D. H., & Wos‐Oxley, M. L. (2012) · Environmental Microbiology Reports · doi:10.1111/j.1758-2229.2011.00313.x · Cited by 54
Verkade, E. J. M., BENTHEM, B. H. B. V., den Bergh, M. K.-V., van Cleef, B., van Rijen, M., Bosch, T., & Kluytmans, J. A. J. W. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit228 · Cited by 60
“Persistent carriage occurs in approximately 20% (range, 12%–30%) of the population; about 30% (range, 16%– 70%) are intermittent carriers, and about 50% (range, 16%– 69%) are noncarriers [15, 18, 19].”
Self-citationLk, K., & Bk, J. (2010) · PubMed · Cited by 60
Michalik, S., Depke, M., Murr, A., Salazar, M. G., Kusebauch, U., Sun, Z., Meyer, T. C., Surmann, K., Pförtner, H., Hildebrandt, P., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10059-w · Cited by 60
Kanjilal, S., Sater, M., Thayer, M. B., Lagoudas, G., Kim, S.-H., Blainey, P. C., & Grad, Y. H. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.01160-17 · Cited by 60
Carr, A., Daley, M. J., Merkel, K. G., & Rose, D. T. T. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2188 · Cited by 60
Germinal-centre reactions in allergic inflammation
Gould, H. J., Takhar, P., Harries, H. E., Durham, S. R., & Corrigan, C. J. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.08.007 · Cited by 60
Intranasal Mupirocin Prophylaxis in Elective Surgery
Trautmann, M., Stecher, J., Hemmer, W., Luz, K., & Panknin, H.-T. (2007) · Chemotherapy · doi:10.1159/000112312 · Cited by 60
Cenizal, M. J., Hardy, R. D., Anderson, M., Katz, K., & Skiest, D. J. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31817e9b79 · Cited by 60
“The pathogenesis of infection with CA-MRSA may be different compared with infection with MSSA or health care–associated MRSA.”
BackgroundInfluentialChi Thuong, T., Dac Tho, N., Thi Hoa, N., Minh Phuong, N. T., Van Tuan, L., Song Diep, T., Lindsay, J., The Dung, N., Van Cam, B., Quoc Thinh, L., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000822 · Cited by 48
“aureus in hospitals and the community [1,2].”
Inducible clindamycin resistance in Staphylococcus aureus isolates recovered from Mashhad, Iran.
Seifi, N., Kahani, N., Askari, E., Mahdipour, S., & Naderi, N. M. (2012) · PubMed Central · Cited by 60
Yu, Y., Zhang, Q., Chang, C., Liu, Y., Yang, Z., Guo, Y., Wang, Y., Galanakis, D. K., Levón, K., & Rafailovich, M. H. (2016) · The Analyst · doi:10.1039/c6an01157h · Cited by 59
Lo, W., Wang, C., Lin, W.-J., Wang, S.-R., Teng, C., Huang, C., & Chen, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015791 · Cited by 62
“aureus colonizes the anterior nares and other body sites, but the anterior nares are the most consistent site of colonization [19].”
BackgroundBeigi, R., & Hanrahan, J. (2007) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/2007/70876 · Cited by 59
Intracellular Staphylococcus aureus Perturbs the Host Cell Ca 2+ Homeostasis To Promote Cell Death
Stelzner, K., Winkler, A.-C., Liang, C., Boyny, A., Ade, C. P., Dandekar, T., Fraunholz, M. J., & Rudel, T. (2020) · mBio · doi:10.1128/mbio.02250-20 · Cited by 59
“S taphylococcus aureus is a Gram-positive pathogen that frequently colonizes part of the human microflora (1).”
Tai, Y. J., Borchard, K., Gunson, T. H., Smith, H. R., & Vinciullo, C. (2013) · Australasian Journal of Dermatology · doi:10.1111/ajd.12028 · Cited by 59
“1.(2) This finding is important as it identifies a group of patients who are at high risk of infection, in whom targeted topical therapy can be used to normalise their risk.”
BackgroundRouse, M. S., Rotger, M., Piper, K. E., Steckelberg, J. M., Scholz, M., Andrews, J., & Patel, R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3187-3191.2005 · Cited by 53
“aureus infection in patients with concomitant human immunodeficiency virus infection, with intravascular devices, undergoing surgical procedures, on hemodialysis or continuous ambulatory peritoneal dialysis, or who have undergone liver transplantation (10, 24, 41, 44).”
BackgroundNasal carriage of Staphylococcus aureus in dairy sheep
Vautor, E., Abadie, G., Guibert, J.-M., Chevalier, N., & Pépin, M. (2005) · Veterinary Microbiology · doi:10.1016/j.vetmic.2004.11.019 · Cited by 59
“Cross-sectional surveys of S. aureus nasal carriage have designated individuals as either carriers or noncarriers (Kluytmans et al., 1997).”
BackgroundInfluentialKluytmans, J. A. J. W. (1998) · Journal of Hospital Infection · doi:10.1016/s0195-6701(98)90201-8 · Cited by 59
Self-citationStaphylococcal Infections: A Historical Perspective
Shinefield, H. R., & Ruff, N. L. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2008.10.007 · Cited by 60
Bisaga, A., Paquette, K., Sabatini, L. M., & Lovell, E. (2008) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2008.03.019 · Cited by 59
Inactivation of Staphylococcus aureus by high pressure processing: An overview
Baptista, I., Rocha, S. M., Cunha, Â., Saraiva, J. A., & Almeida, A. (2016) · Innovative Food Science & Emerging Technologies · doi:10.1016/j.ifset.2016.06.008 · Cited by 58
Bouqellah, N. A., Mohamed, M. M., & Ibrahim, Y. F. (2018) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2018.04.001 · Cited by 58
Clinical S. aureus Isolates Vary in Their Virulence to Promote Adaptation to the Host
Tuchscherr, L., Pöllath, C., Siegmund, A., Deinhardt-Emmer, S., Hoerr, V., Svensson, C.-M., Thilo Figge, M., Monecke, S., & Löffler, B. (2019) · Toxins · doi:10.3390/toxins11030135 · Cited by 49
“Staphylococcus aureus is a very versatile pathogen that often colonizes the epithelial surfaces of healthy individuals [1,2]; but it is also the most common pathogen of the bloodstream, surgical side, and bone infections, which are often complicated, with several sites of metastatic foci, and the development of chroni…”
BackgroundStaphylococcus aureus ATP Synthase Promotes Biofilm Persistence by Influencing Innate Immunity
Bosch, M. E., Bertrand, B. P., Heim, C. E., Alqarzaee, A. A., Chaudhari, S. S., Aldrich, A. L., Fey, P. D., Thomas, V. C., & Kielian, T. (2020) · mBio · doi:10.1128/mbio.01581-20 · Cited by 58
“aureus carriers and up to 60% of the population may be intermittent carriers (5, 6).”
BackgroundLebon, A., Labout, J. A. M., Verbrugh, H. A., Jaddoe, V. W. V., Hofman, A., van Wamel, W. J. B., van Belkum, A., & Moll, H. A. (2009) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpediatrics.2009.117 · Cited by 58
Self-citationNasal carriage of Staphylococcus aureus in house dust mite allergic patients and healthy controls
Riechelmann, H., Essig, A., Deutschle, T., Rau, A., Rothermel, B., & Weschta, M. (2005) · Allergy · doi:10.1111/j.1398-9995.2005.00902.x · Cited by 49
“Patients with additional risk factors for nasal SA carriage such as nasal structural abnormalities (21), concomitant upper airway disease (22), atopic dermatitis (19), previous or concurrent immunotherapy (23, 24) or other conditions associated with increased frequency of skin punctures were excluded.”
BackgroundChamchod, F., & Ruan, S. (2012) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-9-25 · Cited by 58
Lowy, F. D., Miller, M., Cespedes, C. A., Vavagiakis, P., & Klein, R. S. (2003) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-003-0969-4 · Cited by 58
“Subjects colonized with staphylococci are at increased risk of subsequent infection, especially when there is a breach of a mucosal or cutaneous barrier [1, 2].”
BackgroundAl-Rawahi, G. N., Schreader, A. G., Porter, S. D., Roscoe, D. L., Gustafson, R., & Bryce, E. A. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01596-07 · Cited by 57
“aureus than the general population (2, 14).”
BackgroundReview on Epidemiology of Clinical and Subclinical Mastitis on Dairy Cows
Argaw, A. (2016) · Food science and quality management · Cited by 57
Olajuyigbe, O. O., Tolulope, I., & Roger, C. (2017) · African Health Sciences · doi:10.4314/ahs.v17i3.23 · Cited by 57
Association of Staphylococcus aureus Colonization and Pneumonia in the Intensive Care Unit
Paling, F. P., Hazard, D. Y., Bonten, M. J. M., Goossens, H., Jafri, H. S., Malhotra‐Kumar, S., Sifakis, F., Weber, S., Kluytmans, J. A. J. W., & for the ASPIRE-ICU Study Team (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.12741 · Cited by 57
Self-citationNada, H., Gomaa, N., Elakhras, A., Mohamed, R. W., & Baker, R. A. (2011) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2011.09.014 · Cited by 57
Skin and soft-tissue infections: impact of resistant gram-positive bacteria
Wilson, M. A. (2003) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2003.10.006 · Cited by 57
van Cleef, B. A. G. L., van Benthem, B. H. B., Verkade, E. J. M., van Rijen, M. M. L., Kluytmans-van den Bergh, M. F. Q., Graveland, H., Bosch, T., Verstappen, K. M. H. W., Wagenaar, J. A., Bos, M. E. H., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0127190 · Cited by 56
“aureus (MRSA and MSSA combined) carriage rates from this study (23% persistent carriage, 52% intermittent carriage, 25% non-carriage) were comparable to those found in literature [24, 25].”
Self-citationStaphylococcus aureus Infections: New Challenges from an Old Pathogen
Kanafani, Z. A., & Fowler, V. G. (2006) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13086552 · Cited by 62
Roberts, M. C., Soge, O. O., & No, D. B. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00074 · Cited by 56
“It is now thought that ∼20% of population almost always carries S. aureus, another 20% rarely carries S. aureus, and the remaining 60% of the population is intermittently colonized (Kluytmans et al., 1997).”
BackgroundStrategies for and advances in the development ofStaphylococcus aureusprophylactic vaccines
Broughan, J. H., Anderson, R. J., & Anderson, A. S. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.54 · Cited by 56
Aptamers: Molecular Tools for Medical Diagnosis
Özalp, V. C., Kavruk, M., Dilek, Ö., & Bayraç, A. T. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150413154233 · Cited by 56
Collery, M. M., Smyth, D. S., Twohig, J., Shore, A. C., Coleman, D. C., & Smyth, C. J. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47734-0 · Cited by 56
“Staphylococcus aureus is an opportunistic pathogen that can persist in the anterior nares of healthy human carriers (Kluytmans et al., 1997; Peacock et al., 2001; Nouwen et al., 2004; Wertheim et al., 2005).”
BackgroundAnsari, S., Gautam, R., Shrestha, S., Ansari, S. R., Subedi, S. N., & Chhetri, M. R. (2016) · BMC Research Notes · doi:10.1186/s13104-016-2021-7 · Cited by 56
“Nasal carriage of MRSA contributes as a major risk factor for subsequent infection and transmission of this pathogen [7, 8].”
BackgroundKim, H. K., Falugi, F., Missiakas, D. M., & Schneewind, O. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524267113 · Cited by 56
“aureus infection, specifically for skin and soft tissue infection, invasive disease, as well as bacteremia (3, 4).”
BackgroundBystander Selection for Antimicrobial Resistance: Implications for Patient Health
Morley, V. J., Woods, R. J., & Read, A. F. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2019.06.004 · Cited by 56
Han, E., Li, X., Zhang, Y., Zhang, M., Cai, J., & Zhang, X. (2020) · Analytical Biochemistry · doi:10.1016/j.ab.2020.113982 · Cited by 56
Larsson, A., Gustafsson, E., Nilsson, A. C., Odenholt, I., Ringberg, H., & Melander, E. (2011) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2011.562530 · Cited by 56
“The pattern of carriage is changing between the age of 10 and 20 years in a majority of cases [20, 21].”
Biased use of VH5 IgE-positive B cells in the nasal mucosa in allergic rhinitis
Coker, H. A., Harries, H. E., Banfield, G., Carr, V. A., Durham, S. R., Chevretton, E. B., Hobby, P., Sutton, B. J., & Gould, H. J. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.04.032 · Cited by 56
Nobmann, P., Bourke, P., Dunne, J., & HENEHAN, G. T. M. (2009) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2009.04622.x · Cited by 56
“Staphylococcus aureus may occur as a commensal on human skin; it can also be present in the anterior nares, with a mean carriage rate of 37Æ2% in the general population (Kluytmans et al. 1997).”
BackgroundThe profiles of enterotoxin genes in Staphylococcus aureus from nasal carriers
Bania, J., Dąbrowska, A., Korzekwa, K., Żarczyńska, A., Bystroń, J., Chrzanowska, J., & Molenda, J. (2006) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2006.01862.x · Cited by 56
“Approximately 20% of healthy humans are estimated to be persistently colonized by S. aureus, while as many as 60% can be colonized intermittently (Kluytmans et al. 1997).”
BackgroundMiller, R. R., Walker, A. S., Godwin, H., Fung, R., Votintseva, A. A., Bowden, R. J., Mant, D., Peto, T., Crook, D. W., & Knox, K. (2014) · Journal of Infection · doi:10.1016/j.jinf.2013.12.013 · Cited by 56
Miller, M. B., Weber, D. J., Goodrich, J. S., Popowitch, E. B., Poe, M. D., Nyugen, V., Shope, T. R., Foster, D. T., Miller, J. R., & Kotch, J. B. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02235-10 · Cited by 56
“aureus isolates are often identical to strains later causing clinical infection (38, 39) and that when colonization is eradicated the risk of clinical infection is reduced (21).”
BackgroundZakai, S. A. (2015) · Saudi Medical Journal · doi:10.15537/smj.2015.7.11609 · Cited by 55
Multiple-Strain Colonization in Nasal Carriers of Staphylococcus aureus
Votintseva, A. A., Miller, R. R., Fung, R., Knox, K., Godwin, H., Peto, T., Crook, D. W., Bowden, R. J., & Walker, A. S. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03254-13 · Cited by 55
“No other spa types 17 (5) 11 (4) 6 (10)”
BackgroundIs Preoperative Staphylococcal Decolonization Efficient in Total Joint Arthroplasty
Moroski, N. M., Woolwine, S., & Schwarzkopf, R. M. (2014) · The Journal of Arthroplasty · doi:10.1016/j.arth.2014.10.017 · Cited by 55
Dirty hands: photodynamic killing of human pathogens like EHEC, MRSA and Candida within seconds
Eichner, A., Gonzales, F. P., Felgenträger, A., Regensburger, J., Holzmann, T., Schneider‐Brachert, W., Bäumler, W., & Maisch, T. (2012) · Photochemical & Photobiological Sciences · doi:10.1039/c2pp25164g · Cited by 55
Mwenya, D., Charalambous, B. M., Phillips, P. P. J., Mwansa, J. C. L., Batt, S. L., Nunn, A., Walker, A. S., Gibb, D. M., & Gillespie, S. H. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01409-09 · Cited by 55
Singh, K. S., Gavin, P. J., Vescio, T. M., Thomson, R. B., Deddish, R. B., Fisher, A. G., Noskin, G. A., & Peterson, L. R. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.6.2755-2757.2003 · Cited by 55
Staphylococcus aureusin early cystic fibrosis lung disease
Wong, J. K., Ranganathan, S., Hart, E. J., & on behalf of the Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF) (2013) · Pediatric Pulmonology · doi:10.1002/ppul.22863 · Cited by 55
“aureus in the upper airways has been suggested as a means of decreasing the risk of infection.(76) While antimicrobial therapy reduces the prevalence of S.”
BackgroundChen, B., Dai, X., He, B., Pan, K., Li, H., Liu, X., Bao, Y., Lao, W., Wu, X., Yao, Y., et al. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1032-7 · Cited by 54
“Staphylococcus aureus colonizes various body sites, but the anterior nares are the most consistent site of colonization [1].”
Shadyab, A., & Crum‐Cianflone, N. F. (2012) · HIV Medicine · doi:10.1111/j.1468-1293.2011.00978.x · Cited by 54
Staphylococcus aureus (Including Staphylococcal Toxic Shock Syndrome)
Que, Y., & Moreillon, P. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00196-x · Cited by 54
Zhang, F., Ledue, O., Jun, M., Goulart, C., Malley, R., & Lu, Y. (2018) · mBio · doi:10.1128/mbio.01949-18 · Cited by 54
Staphylococcus aureus Exploits the Host Apoptotic Pathway To Persist during Infection
Winstel, V., Schneewind, O., & Missiakas, D. M. (2019) · mBio · doi:10.1128/mbio.02270-19 · Cited by 54
“arthritis, bacteremia, and endocarditis (1, 2).”
Ribau, A., Collins, J. E., Chen, A. F., & de Sousa, R. J. G. (2020) · The Journal of Arthroplasty · doi:10.1016/j.arth.2020.08.014 · Cited by 54
“It has been shown that a significant proportion of patients carry S aureus in their commensal flora and they seem to be at increased risk of infection in multiple clinical settings [48,49].”
BackgroundAlfaro, C., Mascher-Denen, M., Fergie, J., & Purcell, K. (2006) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000215228.25382.bd · Cited by 51
de Carvalho, M. J., Pimenta, F. C., Hayashida, M., Gir, E., da Silva, A. M., Barbosa, C. P., Canini, S. R. M. D. S., & Santiago, S. B. (2009) · Clinics · doi:10.1590/s1807-59322009000400005 · Cited by 54
Corne, P., Marchandin, H., Jonquet, O., Campos, J., & Bañuls, A. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3491-3493.2005 · Cited by 54
“The anterior nares are the main reservoir of S. aureus, and nasal S. aureus carriage appears to play a key role in the pathogenesis of S. aureus infection (5, 7 , 11, 19).”
BackgroundUemura, E., Kakinohana, S., Higa, N., Toma, C., & Nakasone, N. (2004) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2004.21 · Cited by 54
“Many reports have described the rates of nasal carriage in various populations (5).”
BackgroundRajagopalan, G., Iijima, K., Singh, M., Kita, H., Patel, R., & David, C. S. (2006) · Infection and Immunity · doi:10.1128/iai.74.2.1284-1296.2006 · Cited by 54
“While more than half of the pathogenic isolates produce one or more superantigen exotoxins (6, 28, 104), even strains isolated from asymptomatic carriers can produce superantigens (6, 28, 35, 49 , 64, 103).”
BackgroundMolecular mechanisms of Staphylococcus aureus nasopharyngeal colonization
Edwards, A. M., Massey, R. C., & Clarke, S. R. (2011) · Molecular Oral Microbiology · doi:10.1111/j.2041-1014.2011.00628.x · Cited by 56
HTLV‐1‐associated infective dermatitis: updates on the pathogenesis
McGill, N., Vyas, J., Shimauchi, T., Tokura, Y., & Piguet, V. (2012) · Experimental Dermatology · doi:10.1111/exd.12007 · Cited by 47
Covering all the Bases: Preclinical Development of an Effective Staphylococcus aureus Vaccine
Scully, I. L., Liberator, P., Jansen, K. U., & Anderson, A. S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00109 · Cited by 53
Metadata
- Authors
- Kluytmans, J., van Belkum, A., & Verbrugh, H.
- Affiliations
- Ignatius Hospital (NL)
- Ignatius Hospital Breda, The Netherlands.
- ORCID
- Kluytmans, J
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 1997-07
- Volume
- 10
- Issue
- 3
- Pages
- 505-520
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- PMC
- PMC172932
- OpenAlex
- W2111113492
- Cited by
- 2,595
- References
- 217
- Citations by year
- 2026: 38 · 2025: 58 · 2024: 77 · 2023: 73 · 2022: 103 · 2021: 92 · 2020: 99 · 2019: 126 · 2018: 116 · 2017: 152 · 2016: 166 · 2015: 137 · 2014: 162 · 2013: 179 · 2012: 134
- FWCI
- 14.58
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Clinical Microbiology Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Infectious Diseases › Otolaryngology and Infectious Diseases
- Keywords
- Staphylococcus aureus, nasal carriage, methicillin-resistant Staphylococcus aureus, persistent carriage, infection risk factors, hemodialysis, continuous ambulatory peritoneal dialysis, people who inject drugs, HIV infection, surgical patients, intravascular devices, infection control
- MeSH terms
- Bacterial Adhesion, Carrier State, Endothelium, Endothelium, Corneal, Epithelium, Renal Dialysis, Humans, Peritoneal Dialysis, Continuous Ambulatory, Risk Factors, Staphylococcal Infections, Staphylococcus aureus, Surgical Wound Infection, HIV Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.